Bill is a member of the Clinical Genome (ClinGen) Biocuration Core at UNC. He first became interested in the clinical applications of genomics while studying inherited syndromes of cancer predisposition. As a Ph.D. student in Joanna Groden’s lab at The Ohio State University, he used genomics techniques to help characterize a new function of the gene product associated with familial adenomatous polyposis (FAP). He later joined a postdoctoral training program through the Duke Center for Applied Genomics and Precision Medicine, training under Qianben Wang to study how transcription factors reprogram gene expression during the progression of prostate cancer to the treatment-resistant state. As a member of the Berg Lab, he is excited to interact with experts specializing in metabolic disorders, ocular disease, and disorders of hemostasis and thrombosis in order to evaluate novel genetic variants and investigate the genetic basis of these conditions.
Bill is originally from the Boston area and enjoys visiting with family and exploring new parts of North Carolina.
